Q: I own 3000 shares of WELL at $7.56 and have been thinking of averaging down. Do you believe WELL at current $3.69, is a buy for this purpose?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Medical Properties Trust Inc. (MPW $4.31)
-
Community Healthcare Trust Incorporated (CHCT $15.12)
-
LTC Properties Inc. (LTC $36.80)
Q: Discovered this Long Term Care Properties company in the US with monthly dividends of 6%. Do you think this is a stock worth holding to have exposure to US health care? And is dividend sustainable as it seems to have a large payout from my novice analysis. Appreciate your expert analysis very much.
Q: Is ABCL a buy, hold or sell at this point ? Thanks for this great service.
Q: DTC ... YOUR opinion on buying this based on recent publication results
-
Intuitive Surgical Inc. (ISRG $476.16)
-
Medtronic plc. (MDT $92.71)
-
Stryker Corporation (SYK $394.22)
-
Penumbra Inc. (PEN $264.74)
-
Lantheus Holdings Inc. (LNTH $58.21)
Q: Do you have three or four names in the medical equipment sector that you expect will do well this coming year.?
Q: Morning
Your opinion on earnings please, I have a small position and want to slowly add to healthcare for the next leg up whenever that might be.
Your opinion on earnings please, I have a small position and want to slowly add to healthcare for the next leg up whenever that might be.
Q: DRDR just reported their last quarter. While sales are going up, they never seem to make any money, even EBITDA negative. Your thoughts please. Thanks
Q: Any comments or opinions about today's announced bought deal of new shares of Well? The offering price seems low, it looks as though they waited for a dip to make the offering. Are we existing shareholders getting a raw deal?
Q: Under the "lottery ticket" portion of my portfolio I own SVA, they announced a deal with EVO. RBC has no information on EVO, what can you tell me about EVO, thoughts on the deal?
-
Health Care Select Sector SPDR (XLV $138.17)
-
iShares Biotechnology ETF (IBB $139.84)
-
Harvest Healthcare Leaders Income ETF (HHL.U $8.00)
Q: Good Morning
Can you please give your opinion on Harvest Healthcare Leaders ETF or is there another healthcare purchase you would suggest.
Also would this be a good time to purchase.
Thank you
Heather
Can you please give your opinion on Harvest Healthcare Leaders ETF or is there another healthcare purchase you would suggest.
Also would this be a good time to purchase.
Thank you
Heather
Q: there's some fringe companies doing experiments with magic mushrooms to treat anxiety, depression and a number of other ailments. If this takes off do you think this could have lots of upside , or will this be attacked by large drug makers whose patented drugs could loose market share ? Thanks alot.
Q: Please comment on earnings
Q: Hi,
If choosing between Pfizer and Merck today for a long term hold (5-10 years), which would you choose and why please. Thanks very much.
Michael
If choosing between Pfizer and Merck today for a long term hold (5-10 years), which would you choose and why please. Thanks very much.
Michael
Q: To me WELL is hitting on all cylinders but it is unloved within the market. This from it's latest results:
WELL reported record quarterly revenues of $126.5 million in Q1-2022 representing a 395% year-over-year (YoY) increase compared to Q1-2021, catapulting the Company to over $500 million annualized revenue run-rate. Revenues reflected accelerating organic growth to 15% on a YoY basis
I have held it for a while now and am under water. Granted we are in a down market but do you think this stock will get more attention once the market hits bottom [when ever that is] and starts to move up?
Thanks
WELL reported record quarterly revenues of $126.5 million in Q1-2022 representing a 395% year-over-year (YoY) increase compared to Q1-2021, catapulting the Company to over $500 million annualized revenue run-rate. Revenues reflected accelerating organic growth to 15% on a YoY basis
I have held it for a while now and am under water. Granted we are in a down market but do you think this stock will get more attention once the market hits bottom [when ever that is] and starts to move up?
Thanks
Q: will SIS be able to keep paying dividends? Thanks.
Q: Please comment on Savaria Corps earnings. Thanks.
Q: Your comment on the last result .
Thank you
Thank you
Q: Please comment on its earnings. How do you think it is as a long term holding?
Q: what does the market expect from savaria this quarter?
Thx
Thx
-
Amgen Inc. (AMGN $293.72)
-
Regeneron Pharmaceuticals Inc. (REGN $589.48)
-
Vertex Pharmaceuticals Incorporated (VRTX $395.12)
-
iShares Biotechnology ETF (IBB $139.84)
-
Mettler-Toledo International Inc. (MTD $1,321.45)
-
Solid Biosciences Inc. (SLDB $5.93)
-
TCR2 Therapeutics Inc. (TCRR)
-
NextCure Inc. (NXTC $5.13)
Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?